RK

Ritu Kataria

Director Director DIN 01111270
DIN 01111270 First appointment Nov 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2004
Shareholding value •••• Premium profile

About Ritu Kataria

Data last updated:

Ritu Kataria was a Director at Bhasin Sales Private Limited (2013–2023) and Director at V Pharma Labs Private Limited (2004–2013). The companies operate in Pharma and Business Services.

DIN 01111270
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhasin Sales Private Limited U46900UP1979PTC004813
Director03 Jul 20131979₹60.3 Lakh (FY 2025)Active
V Pharma Labs Private Limited U51109UP1974PTC003926
Director01 Nov 20041974Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bhasin Sales Private Limited
V Pharma Labs Private Limited
Premium access

Shareholding and investment profile for Ritu Kataria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Kataria

Ritu Kataria was first appointed on 01 Nov 2004 as Director at V Pharma Labs Private Limited. The most recent appointment on record is 03 Jul 2013 at Bhasin Sales Private Limited.

Ritu Kataria held 2 earlier board appointments: Bhasin Sales Private Limited (Director, 03 Jul 2013 to 05 Aug 2023); V Pharma Labs Private Limited (Director, 01 Nov 2004 to 25 Jun 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available